Vir Biotechnology and GlaxoSmithKline (GSK) are stopping a Phase 3 clinical trial of its COVID-19 antibody early after data shows “profound efficacy,” according to a recent announcement...
The Medicines and Healthcare products Regulatory Agency (MHRA) and European Medicines Agency (EMA) recently reaffirmed the benefits of AstraZeneca’s COVID-19 vaccine.
The agencies stated that...
Eli Lilly and Company and Biolojic Design recently announced a research agreement to discover and develop potential novel antibody therapies for the treatment of diabetes.
The collaboration and...
Researchers recently developed a promising new blueprint for an RNA-based vaccine for malaria, which contains similar properties as the novel RNA COVID-19 vaccines.
Novartis Pharmaceutical and...
GSK recently announced results from a Phase 2 proof-of-concept trial evaluating its investigational monoclonal antibody treatment, otilimab.
The OSCAR study evaluated the efficacy and safety of...
Moderna recently announced that it has shipped doses of its variant-specific COVID-19 vaccine candidate to the National Institutes of Health (NIH) for a Phase 1 clinical trial.
NIAID will conduct the...
Racial and ethnic diversity in clinical trials is lacking despite FDA recommendations regarding demographic characteristics of specific study populations, according to a recent JAMA Network Open...
Pfizer and BioNTech recently announced that the first participants have been dosed in a global Phase 2/3 study to further evaluate their COVID-19 vaccine in healthy pregnant women.
The randomized,...
Pharmaceutical company bluebird bio recently announced that it suspended Phase 1/2 and Phase 3 studies of LentiGlobin gene therapy for sickle cell disease due to a suspected unexpected serious adverse...
GSK recently announced that the first patient has been dosed in a Phase 3 clinical program investigating the immunogenicity, safety, and reactogenicity of a RSV vaccine candidate for older...
AbbVie and Caribou Biosciences recently entered into a collaboration and license agreement to research and develop chimeric antigen receptor (CAR)-T cell therapeutics.
The companies will leverage...
FDA recently approved Bristol Meyer Squibb’s CAR-T cell therapy Breyanzi for the treatment of certain types of large B-cell lymphoma in patients who have not responded to previous treatment...
Siemens Healthineers recently announced that it received the CE mark to use anterior nose swab sampling for its COVID-19 antigen test.
The CLINITEST Rapid COVID-19 Antigen Test is a point-of-care...
Roche recently announced that it received the CE mark for its new self-administered COVID-19 antigen test, which will be available in countries accepting the CE mark by the middle of this...
The Feinstein Institutes for Medical Research, part of Northwell Health, and Cold Spring Harbor Laboratory (CSHL) recently launched a fully virtual clinical trial to evaluate the safety and efficacy of...
Eli Lilly and Company recently announced that its COVID-19 neutralizing antibodies reduced coronavirus-related hospitalizations and deaths in high-risk patients by 70 percent in a Phase 3...
Eli Lilly and Company, Vir Biotechnology, and GSK recently collaborated to evaluate a combination of two COVID-19 therapies in low-risk patients with mild to moderate coronavirus.
Eli Lilly and...
GSK and Novartis recently announced a research collaboration to uncover potential links between genetic diversity across regions in Africa and drug response and ultimately drug development.
The...
Johnson & Johnson recently announced that a single-dose of its COVID-19 vaccine candidate, Ad26.COV2.S, was 66 percent effective at preventing moderate to severe coronavirus in a Phase 3 clinical...
Moderna recently announced that clinical trial researchers have dosed the first in the Phase 1/2 study of its mRNA COVID-19 vaccine, mRNA-1273, in Japan, led by Takeda Pharmaceuticals.
The...
